The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors

被引：28
|
作者：
Patel, M
Kaltenbach, RF
Nugiel, DA
McHugh, RJ
Jadhav, PK
Bacheler, LT
Cordova, BC
Klabe, RM
Erickson-Viitanen, S
Garber, S
Reid, C
Seitz, SP
机构：
[1] Dupont Merck Pharmaceut Co, Expt Stn, Dept Chem & Phys Sci, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Expt Stn, Dept Virol, Wilmington, DE 19880 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 09期
关键词：
D O I：
10.1016/S0960-894X(98)00175-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cyclic urea SD146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further development of the compound. In an effort to improve upon the pharmacokinetic profile of the compound, several analogs modified at the P1/P1' residues were prepared and evaluated. Several of those compounds displayed significant improvement of physical properties. (C) 1998 The DuPont Merck Pharmaceutical Company. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1077 / 1082
页数：6
相关论文
共 50 条
  • [41] Bound on Seshadri constants on P1 x P1
    De Volder, Cindy
    Tutaj-Gasinska, Halszka
    BULLETIN OF THE BELGIAN MATHEMATICAL SOCIETY-SIMON STEVIN, 2009, 16 (05) : 823 - 829
  • [42] A new synthesis of symmetrical P1,P2-dinucleoside-5′-pyrophosphates
    Kim, KB
    Behrman, EJ
    NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (01): : 51 - 54
  • [43] Rational curves on K3 surfaces in P1 x P1 x P1
    Baragar, A
    PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 1998, 126 (03) : 637 - 644
  • [44] Segre-Veronese embeddings of P1 x P1 x P1 and their secant varieties
    Catalisano, M. V.
    Geramita, A. V.
    Gimigliano, A.
    COLLECTANEA MATHEMATICA, 2007, 58 (01) : 1 - 24
  • [45] Potent and selective aggrecanase inhibitors containing cyclic P1 substituents
    Cherney, RJ
    Mo, RW
    Meyer, DT
    Wang, L
    Yao, WQ
    Wasserman, ZR
    Liu, RQ
    Covington, MB
    Tortorella, MD
    Arner, EC
    Qian, MX
    Christ, DD
    Trzaskos, JM
    Newton, RC
    Magolda, RL
    Decicco, CP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (07) : 1297 - 1300
  • [46] Design, synthesis and evaluation of diaroyl cyclic ureas as Factor Xa inhibitors utilizing a neutral P1 residue as arginine surrogate.
    Cui, J
    Alkassoum, S
    Zhou, YS
    Wanna, L
    Crich, D
    Johnson, ME
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1180 - U1180
  • [47] Synthesis of P1′-Functionalized Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol
    De Rosa, Maria
    Unge, Johan
    Motwani, Hitesh V.
    Rosenquist, Asa
    Vrang, Lotta
    Wallberg, Hans
    Larhed, Mats
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6444 - 6457
  • [48] Combinatorial enumeration of cyclic covers of P1
    Besana, Alberto
    Martinez, Cristina
    TURKISH JOURNAL OF MATHEMATICS, 2018, 42 (04) : 2018 - 2034
  • [49] Special arrangements of lines: Codimension 2 ACM varieties in P1 x P1 x P1
    Favacchio, Giuseppe
    Guardo, Elena
    Picone, Beatrice
    JOURNAL OF ALGEBRA AND ITS APPLICATIONS, 2019, 18 (04)
  • [50] Design, synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1′ ligand
    Dou, Yue
    Zhu, Mei
    Dong, Biao
    Wang, Ju-Xian
    Zhang, Guo-Ning
    Zhang, Fan
    Wang, Yu-Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (07)
12345